Additio Investment Group
Additio Investment Group is a Barcelona-based private investment firm founded in 2019 that backs high-integrity entrepreneurs building healthcare and life sciences businesses. It operates with a 1-10 employee team focused on founder-led ventures in the sector.
- Company typePrivate
- Founded2019
- HeadquartersBarcelona, Spain
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Additio Investment Group does
Additio Investment Group is a private investment firm founded in 2019 and headquartered in Barcelona, Spain. According to its firmographic profile, the firm supports "high-integrity entrepreneurs with the potential to build great businesses in Healthcare and Life Sciences," indicating a sector-focused investment mandate targeting founder-led companies in the European healthcare and life sciences ecosystem. The firm operates with a small team of 1-10 employees, consistent with an emerging or boutique investment vehicle rather than a scaled platform.
The firm's underlying business model, investment vehicles, and revenue mechanics cannot be determined from the available source data. The corporate website (additioinvestmentgroup.com) currently serves only a verification/loading page, blocking access to fund disclosures, portfolio information, team details, partnership announcements, or press activity. No funding rounds, portfolio investments, M&A activity, leadership changes, regulatory actions, or product launches are evidenced in the source material. No customer logos, LP roster, pricing models, or technology stack information are available. As such, any deeper characterization of revenue model, go-to-market, deal cadence, or competitive positioning cannot be substantiated beyond the stated sector focus.
For a PE/VC diligence audience, the most material observation is the absence of public-facing traction signals: no disclosed AUM, no named portfolio companies, no announced fund vintages, and no team bios accessible. The investment thesis (healthcare/life sciences founder backing in Barcelona) is plausible and aligned with a recognized European biotech/healthtech corridor, but verification of fund size, traction, and team depth requires off-platform due diligence.
Additio Investment Group firmographics
Firmographics- Name
- Additio Investment Group
- Website
- https://additioinvestmentgroup.com
- Company type
- Private
- Founded year
- 2019
- Headcount range
- 1–10 employees
- Short description
- Additio Investment Group is a Barcelona-based private investment firm founded in 2019 that backs high-integrity entrepreneurs building healthcare and life sciences businesses. It operates with a 1-10 employee team focused on founder-led ventures in the sector.
- Ownership category
- akta.pro rank
Where Additio Investment Group is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Markets served
Additio Investment Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
Additio Investment Group product offering
Product offeringCore offering
Additio Investment Group is a private investment firm that supports high-integrity entrepreneurs with the potential to build great businesses in the Healthcare and Life Sciences sectors. Founded in 2019 and headquartered in Barcelona, Spain, the firm provides capital and backing to early-stage ventures in these industries.
Product overview
Limited information available. The website displays a verification/waiting page without access to actual product or service content.
Differentiator
Problem solved
Functional benefit
Products and services
- Healthcare and Life Sciences Investment Support
Companies that use Additio Investment Group
Customer profileIdeal customer profiles1 record
Additio Investment Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Additio Investment Group partnerships and signals
Strategic signalRecent moves1 record
Additio Investment Group competitors and assessment
Company assessmentDirect peers
- Ysios Capital: Spanish venture capital firm specializing in life sciences and healthcare, based in Barcelona/San Sebastian. Directly comparable as a healthcare-vertical specialist operating from the same Iberian ecosystem and targeting similar European biotech opportunities.
- Asabys Partners: Barcelona-based venture capital firm focused on healthcare and life sciences, investing in early-stage companies across therapeutics, medtech, and digital health. Comparable geography, sector focus, and stage.
- Medicxi: European life sciences-focused investment firm managing multiple funds across venture and growth stages. Comparable as a dedicated healthcare/life sciences specialist with a multi-fund platform approach.
- Kurma Partners: European healthcare and biotech venture capital firm with active presence in Spain and France. Comparable as a sector-focused investor targeting European life sciences innovation.
- Forbion: Pan-European life sciences venture capital firm managing venture and growth funds in biotech and medical technology. Comparable as a sector-focused specialist with multi-stage capabilities in healthcare.
- Gilde Healthcare: Dutch-based healthcare investor covering venture and growth stages across therapeutics, medtech, and digital health. Comparable as a dedicated healthcare specialist with European focus.
- BioGeneration Ventures (BGV): European venture capital firm focused exclusively on early-stage biotech and life sciences. Comparable as a sector-focused specialist with early-stage European biotech focus.
- Novo Seeds: Early-stage healthcare and biotech venture arm of Novo Holdings, investing in European life sciences. Comparable as a sector-focused specialist targeting similar venture-stage opportunities.
- Andera Partners: European private equity and venture capital firm with a dedicated Life Sciences practice covering biotech, medtech, and diagnostics. Comparable as a healthcare-specialist with European multi-stage mandate.
Regional players
- Caixa Capital Risc: Spanish venture capital firm (part of CriteriaCaixa) investing across sectors including healthcare and life sciences. Comparable as a Barcelona-based VC active in the Spanish biotech ecosystem, though broader in sector scope.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Customer concentration
Additio Investment Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Additio Investment Group leadership team
Management profileNumber of profiles
Additio Investment Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Additio Investment Group M&A and investment
M&A and investmentM&A
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Additio Investment Group
What does Additio Investment Group do?
Additio Investment Group is a private investment firm that supports high-integrity entrepreneurs with the potential to build great businesses in the Healthcare and Life Sciences sectors. Founded in 2019 and headquartered in Barcelona, Spain, the firm provides capital and backing to early-stage ventures in these industries.
When was Additio Investment Group founded?
Additio Investment Group was founded in 2019. It employs 1 to 10 people.
Where is Additio Investment Group based?
Additio Investment Group is headquartered in Barcelona, Spain, in the Europe region.
Who are Additio Investment Group's main competitors?
Direct peers on record are Ysios Capital, Asabys Partners, Medicxi, Kurma Partners, Forbion, Gilde Healthcare, BioGeneration Ventures (BGV), Novo Seeds and Andera Partners. Caixa Capital Risc is listed as a regional player.
Does Additio Investment Group have an API?
No public API is recorded for Additio Investment Group.